Invention Application
- Patent Title: S100A12 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
-
Application No.: US17575202Application Date: 2022-01-13
-
Publication No.: US20220137069A1Publication Date: 2022-05-05
- Inventor: Aikaterini GEORGOPOULOU , Feliz GRUENEWALD , Martin HUND , Martin KLAMMER , Heike WEGMEYER
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Priority: EP19187477.5 20190722
- Main IPC: G01N33/68
- IPC: G01N33/68
Abstract:
The present invention relates to methods of assessing whether a patient has endometriosis or is at risk of developing endometriosis, to methods of selecting a patient for therapy, and method of monitoring a patient suffering from endometriosis or being treated for endometriosis by determining the amount or concentration of S100A12 in a sample of the patient, and comparing the determined amount or concentration to a reference.
Information query
IPC分类:
